Marazziti Donatella, Albert Umberto, Dell'Osso Bernardo, Tundo Antonio, Cuniberti Francesco, Maina Giuseppe, Moroni Ilenia, Benatti Beatrice, Mucci Federico, Massimetti Gabriele, Piccinni Armando, Brakoulias Vlasios
Dipartimento di Medicina Clinica e Sperimentale, Section of Psychiatry, University of Pisa, Pisa, Italy.
Rita Levi Montalcini Department of Neuroscience, University of Turin, and San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Hum Psychopharmacol. 2017 Nov;32(6). doi: 10.1002/hup.2641. Epub 2017 Oct 2.
The aim of the present study was to investigate psychopharmacological prescribing patterns in a large sample (n = 1815) of patients suffering from obsessive-compulsive disorder (OCD) recruited in 4 Italian centers specialized in OCD, in comparison to available national and international guidelines. The centers were asked to complete a specific data sheet questionnaire on patients' therapeutic status. Statistical analyses were carried out by SPSS. The results showed that almost all patients referred to the centers of Milan, Pisa and Rome received psychotropic medications, whereas only 59.9% (313) did so in Turin. Selective serotonin reuptake inhibitors were the most used drugs ranging between 49.0% and 71.5%. Clomipramine was prescribed more often in Rome and Pisa than in Milan and Turin. The same was true for other tricyclic antidepressants. Second-generation antipsychotics were more often prescribed in Pisa and in Milan. Mood stabilizers were almost exclusively used in Pisa. Taken together, the overall findings would suggest that, although the main Italian centers specialized in OCD follow available guidelines, a certain degree of variability does exist. This may depend on the different educational background, availability of other specific therapeutic strategies, as well as varying levels of severity and comorbidity of the patients.
本研究的目的是,与现有的国家和国际指南相比,调查在意大利4个专门治疗强迫症(OCD)的中心招募的大量样本(n = 1815)强迫症患者的精神药物处方模式。要求这些中心填写一份关于患者治疗状况的特定数据表问卷。使用SPSS进行统计分析。结果显示,几乎所有转诊至米兰、比萨和罗马中心的患者都接受了精神药物治疗,而在都灵只有59.9%(313例)的患者接受了精神药物治疗。选择性5-羟色胺再摄取抑制剂是使用最多的药物,使用率在49.0%至71.5%之间。氯米帕明在罗马和比萨的处方量比在米兰和都灵更多。其他三环类抗抑郁药的情况也是如此。第二代抗精神病药物在比萨和米兰的处方量更多。心境稳定剂几乎只在比萨使用。总体而言,研究结果表明,尽管意大利主要的强迫症治疗中心遵循现有指南,但确实存在一定程度的差异。这可能取决于不同的教育背景、其他特定治疗策略的可用性,以及患者不同的严重程度和共病情况。